Tag: biomedical data

Ardigen and VERAXA Biotech are collaborating to enhance cancer therapy development through AI-driven target pair selection, aiming to optimize T cell engagers and antibody-drug conjugates. This approach could significantly improve patient outcomes by minimizing side effects and improving therapeutic efficacy. Read more